Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group.

@article{Braun1998CalciumCB,
  title={Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group.},
  author={Siegmund Braun and Valerij Volodimyrovich Boyko and Stella B{\'e}har and Henrietta Reicher-Reiss and Shiomo Laniado and Elieser Kaplinsky and Uri Goldbourt},
  journal={Journal of the American College of Cardiology},
  year={1998},
  volume={31 4},
  pages={
          804-8
        }
}
OBJECTIVES This analysis sought to estimate the risk ratio for cancer incidence and cancer-related mortality associated with the use of calcium channel blocking agents (CCBs) in a large group of patients with chronic coronary heart disease (CHD). BACKGROUND Recent publications contend that the use of short-acting CCBs may double the risk of cancer incidence and possibly increase mortality in hypertensive patients. METHODS Cancer incidence data were obtained for 11,575 patients screened for… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

EVIDENCE ON THE CARCINOGENICITY OF VERAPAMIL DRAFT August 2004

  • 2004
VIEW 8 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Calcium Antagonists and Cancer: Causation or Association?

  • Cardiovascular Drugs and Therapy
  • 1998
VIEW 2 EXCERPTS
CITES BACKGROUND & METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 12 REFERENCES

Long - term survival after myocardial infarction : relationship with thrombolysis and discharge medication — results of the Augsburg myocardial infarction follow - up study 1985 – 1993

W Koenig, H Lowel, M Lewis, A Hormann
  • Eur Heart J
  • 1996

The calcium blocker scare: lesson for the future. Circulation 1995;91:2855–6

C. Lenfant
  • 1995
VIEW 1 EXCERPT

Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication—results of the Augsburg myocardial infarction follow-up study

W Koenig, H Lowel, M Lewis, A. Hormann
  • Eur Heart J 1996;17:1199–206
  • 1985
VIEW 1 EXCERPT

Similar Papers